等待開盤 09-25 09:30:00 美东时间
-0.140
-1.10%
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从14美元升至14.5美元;HC Wainwright & Co.:维持Generate Biomedicines"买入"评级,目标价从25美元升至30美元
08-31 18:14
Scotiabank analyst Orest Wowkodaw maintains Nexa Res (NYSE:NEXA) with a Sector Perform and raises the price target from $14 to $15.
08-29 03:10
Boliden AB已与Votorantim签署最终协议,将收购Votorantim所持有的全部Nexa Resources股份,从而获得这家拉丁美洲锌及白银生产商约64.68%的多数投票权。
08-28 10:06
STOCKHOLM, Aug. 27, 2026 /PRNewswire/ -- Boliden AB ("Boliden") and Votorantim S.A. ("Votorantim") have entered into a definitive agreement (the "Transaction") pursuant to which Boliden will...
08-27 13:16
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24
Scotiabank analyst Orest Wowkodaw maintains Nexa Res (NYSE:NEXA) with a Sector Perform and lowers the price target from $15 to $14.
08-08 09:04
Nexa Resources’ Q2 2026 earnings showed net revenue of US$908 million, up 28% year over year, net income of US$98 million versus US$13 million, and adjusted EBITDA of US$286 million, up 78%. Higher zinc prices, stronger by-product contributions, more concentrate from Nexa’s own mines, lower operating costs, and recovering Peruvian operations supported the quarter. Mining zinc output rose 8%, while smelting production fell 10% after the Cajamarqui
08-05 23:10
今日重点评级关注:HC Wainwright & Co.:维持居里"买入"评级,目标价从17美元升至43美元;花旗:维持Klaviyo"买入"评级,目标价从31美元升至34美元
07-27 14:02
JP Morgan analyst Rodolfo Angele maintains Nexa Res (NYSE:NEXA) with a Neutral and raises the price target from $7.5 to $15.5.
07-25 01:56
今日重点评级关注:HC Wainwright & Co.:维持Rockwell Medical"买入"评级,目标价从2美元升至20美元;Canaccord Genuity:维持创力"买入"评级,目标价从10.5美元升至11美元
07-10 17:36